ID   EPAS1_RAT               Reviewed;         874 AA.
AC   Q9JHS1;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   27-MAR-2024, entry version 162.
DE   RecName: Full=Endothelial PAS domain-containing protein 1;
DE            Short=EPAS-1;
DE   AltName: Full=Hypoxia-inducible factor 2-alpha;
DE            Short=HIF-2-alpha;
DE            Short=HIF2-alpha;
GN   Name=Epas1; Synonyms=Hif2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=11237857; DOI=10.1042/0264-6021:3540531;
RA   Kietzmann T., Cornesse Y., Brechtel K., Modaressi S., Jungermann K.;
RT   "Perivenous expression of the mRNA of the three hypoxia-inducible factor a-
RT   subunits HIF-1a, HIF2a and HIF3a in rat liver.";
RL   Biochem. J. 354:531-537(2001).
CC   -!- FUNCTION: Transcription factor involved in the induction of oxygen
CC       regulated genes. Heterodimerizes with ARNT; heterodimer binds to core
CC       DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of
CC       target gene promoters (By similarity). Regulates the vascular
CC       endothelial growth factor (VEGF) expression and seems to be implicated
CC       in the development of blood vessels and the tubular system of lung. May
CC       also play a role in the formation of the endothelium that gives rise to
CC       the blood brain barrier. Potent activator of the Tie-2 tyrosine kinase
CC       expression. Activation requires recruitment of transcriptional
CC       coactivators such as CREBBP and probably EP300. Interaction with redox
CC       regulatory protein APEX seems to activate CTAD (By similarity).
CC       {ECO:0000250, ECO:0000250|UniProtKB:P97481}.
CC   -!- SUBUNIT: Interacts with HIF3A2. Efficient DNA binding requires
CC       dimerization with another bHLH protein. Heterodimerizes with ARNT;
CC       heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia
CC       response element (HRE) of target gene promoters. Interacts with CREBBP
CC       (By similarity). Interacts with EGLN1. Interacts with VHL (By
CC       similarity). {ECO:0000250|UniProtKB:P97481,
CC       ECO:0000250|UniProtKB:Q99814}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P97481,
CC       ECO:0000255|PROSITE-ProRule:PRU00981}. Nucleus speckle
CC       {ECO:0000250|UniProtKB:P97481}. Note=Colocalizes with HIF3A in the
CC       nucleus and speckles. {ECO:0000250|UniProtKB:P97481}.
CC   -!- PTM: In normoxia, is probably hydroxylated on Pro-405 and Pro-530 by
CC       EGLN1/PHD1, EGLN2/PHD2 and/or EGLN3/PHD3. The hydroxylated prolines
CC       promote interaction with VHL, initiating rapid ubiquitination and
CC       subsequent proteasomal degradation. Under hypoxia, proline
CC       hydroxylation is impaired and ubiquitination is attenuated, resulting
CC       in stabilization (By similarity). {ECO:0000250}.
CC   -!- PTM: In normoxia, is hydroxylated on Asn-851 by HIF1AN thus probably
CC       abrogating interaction with CREBBP and EP300 and preventing
CC       transcriptional activation. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on multiple sites in the CTAD. {ECO:0000250}.
CC   -!- PTM: The iron and 2-oxoglutarate dependent 3-hydroxylation of
CC       asparagine is (S) stereospecific within HIF CTAD domains.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ277828; CAB96612.1; -; mRNA.
DR   RefSeq; NP_075578.1; NM_023090.1.
DR   AlphaFoldDB; Q9JHS1; -.
DR   SMR; Q9JHS1; -.
DR   BioGRID; 248095; 2.
DR   STRING; 10116.ENSRNOP00000075020; -.
DR   PhosphoSitePlus; Q9JHS1; -.
DR   PaxDb; 10116-ENSRNOP00000033874; -.
DR   DNASU; 29452; -.
DR   GeneID; 29452; -.
DR   KEGG; rno:29452; -.
DR   UCSC; RGD:68404; rat.
DR   AGR; RGD:68404; -.
DR   CTD; 2034; -.
DR   RGD; 68404; Epas1.
DR   eggNOG; KOG3558; Eukaryota.
DR   InParanoid; Q9JHS1; -.
DR   OrthoDB; 5396877at2759; -.
DR   PhylomeDB; Q9JHS1; -.
DR   Reactome; R-RNO-1234158; Regulation of gene expression by Hypoxia-inducible Factor.
DR   Reactome; R-RNO-1234174; Cellular response to hypoxia.
DR   Reactome; R-RNO-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-RNO-8951664; Neddylation.
DR   PRO; PR:Q9JHS1; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0050897; F:cobalt ion binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0001892; P:embryonic placenta development; ISO:RGD.
DR   GO; GO:0002070; P:epithelial cell maturation; ISO:RGD.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0007005; P:mitochondrion organization; ISO:RGD.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0060586; P:multicellular organismal-level iron ion homeostasis; ISO:RGD.
DR   GO; GO:0048625; P:myoblast fate commitment; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0042421; P:norepinephrine biosynthetic process; IMP:RGD.
DR   GO; GO:0042415; P:norepinephrine metabolic process; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:1903181; P:positive regulation of dopamine biosynthetic process; IMP:RGD.
DR   GO; GO:1904655; P:positive regulation of lung alveolus development; IEP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0002027; P:regulation of heart rate; ISO:RGD.
DR   GO; GO:2000434; P:regulation of protein neddylation; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:RGD.
DR   GO; GO:0043129; P:surfactant homeostasis; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007601; P:visual perception; ISO:RGD.
DR   CDD; cd19728; bHLH-PAS_HIF2a_PASD2; 1.
DR   CDD; cd00130; PAS; 2.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   Gene3D; 3.30.450.20; PAS domain; 2.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR014887; HIF-1_CTAD.
DR   InterPro; IPR021537; HIF_alpha-like.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR001067; Nuc_translocat.
DR   InterPro; IPR001610; PAC.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013767; PAS_fold.
DR   NCBIfam; TIGR00229; sensory_box; 2.
DR   PANTHER; PTHR23043:SF8; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; 1.
DR   PANTHER; PTHR23043; HYPOXIA-INDUCIBLE FACTOR 1 ALPHA; 1.
DR   Pfam; PF11413; HIF-1; 1.
DR   Pfam; PF08778; HIF-1a_CTAD; 1.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF14598; PAS_11; 1.
DR   PRINTS; PR00785; NCTRNSLOCATR.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00086; PAC; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   SUPFAM; SSF55785; PYP-like sensor domain (PAS domain); 2.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS50112; PAS; 2.
PE   2: Evidence at transcript level;
KW   Activator; Angiogenesis; Developmental protein; Differentiation;
KW   DNA-binding; Hydroxylation; Nucleus; Phosphoprotein; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..874
FT                   /note="Endothelial PAS domain-containing protein 1"
FT                   /id="PRO_0000127421"
FT   DOMAIN          14..67
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   DOMAIN          84..154
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          230..300
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          304..347
FT                   /note="PAC"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          26..53
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P97481"
FT   REGION          171..192
FT                   /note="Required for heterodimer formation with ARNT"
FT                   /evidence="ECO:0000250|UniProtKB:P97481"
FT   REGION          440..487
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          495..541
FT                   /note="NTAD"
FT   REGION          624..677
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          777..824
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          834..874
FT                   /note="CTAD"
FT   COMPBIAS        441..487
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         405
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         530
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         844
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P97481"
FT   MOD_RES         851
FT                   /note="(3S)-3-hydroxyasparagine"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   874 AA;  96718 MW;  A1FF08EB24369796 CRC64;
     MTADKEKKRS SSELRKEKSR DAARCRRSKE TEVFYELAHE LPLPHSVSSH LDKASIMRLA
     ISFLRTHKLL SSVCSENESE AEADQQMDNL YLKALEGFIA VVTQDGDMIF LSENISKFMG
     LTQVELTGHS IFDFTHPCDH EEIRENLTLK TGSGFGKKNK DRSTERDFFM RMKCTVTNRG
     RTVNLKSATW KVLHCTGQVR VYNNCPPHSS LCGYKEPLLS CLIIMCEPIQ HPSHMDIPLD
     SKTFLSRHSM DMKFTYCDDR ILELVGYHPE ELLGRSAYEF YHALDSENMT KSHQNLCTKG
     QVVSGQYRML AKHGGYVWLE TQGTVVYNPR NLQPQCIMCV NYVLSEIEKN DVVVSMDQTE
     SCSSHTLMAM NSIFDTSDDV ALSEKSNYLF TNLKEEPEDL AQLAPTPGDA IISLDFGSQN
     FDESSTYGKA ILPPGQPWAT ELRSHSAQSE SRSLPAFTVP QAGSPGNATP SATSSSSCST
     PSSPEDYYSS LENHLKIEVI EKLFAMDTEA KDQCSTQTDF NELDLETLAP YIPMDGEDFQ
     LSPICPEEPL VPESPQPNPQ HCFSTMSSIF QPLTPGASQG TFFLDKYPQQ LESRKTESEH
     WPMSTIFFDA GSKGSLPPCC GQASTPLSSM GGRSNTPWPP DPPLHLGPTK WSVGNQSAEP
     LGPLPLGTSQ LEPPSTPPHV SMFKMRSAKD FGARGPYMMS PAMIALSNKL KLKRQLDYEE
     PAFQDTSGGD PPGTSSSHLM WKRMKSLMGG TCPLMPDKTV SASMAPDEFT QKSMRGLGQP
     LRHLPPSQPP STRSPGENAK SGFPPQCYAS PFQDYSPPGA QKGSGVASRL LGPSFEPYLL
     PELTRYDCEV NVPEPGSSTL LQGRDLLRAL DQAT
//
